1.
Molica M, Giannarelli D, De Fazio L, Rossi M, Perrone S. CPX-351 in secondary/high-risk acute myeloid leukemia: a meta-analysis of randomized and real-world studies encompassing more than 3200 patients. haematol [Internet]. 2020Sep.10 [cited 2025Dec.19];. Available from: https://haematologica.org/article/view/13049